Solana Beach, CA, United States of America

Brian Lannutti

This inventor holds 20 USPTO granted patents and 36 published patent applications, plus 1 CIPO patent and 7 EPO patents. Top assignees: Acerta Pharma B.v., Oncternal Therapeutics, Inc., Gilead Calistoga LLC. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brian Lannutti. Retrieved from https://idiyas.com/inventor/brian-lannutti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 (Patent Applications = 36)

% Patents Active = 95.0

CIPO Patents = 1 (Patent Applications = 6)

EPO Patents = 7 (Patent Applications = 20)

Average Co-Inventor Count = 4.9

ph-index = 3

Forward Citations = 36(Granted Patents)

Location History:

Seattle, WA (US) (2013 - 2016)
San Diego, CA (US) (2018)
Solana Beach, CA (US) (2018 - 2023)

Company Filing History:

Oncternal Therapeutics, Inc.

Solve Therapeutics, Inc.

patent

Years Active: 2013-2026

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12655217 - ANTI-ROR1 / ANTI-CD3 BISPECIFIC BINDING MOLECULES (2026-06-16),

2. 12534529 - PTK7-Binding Proteins (2026-01-27),

3. RE50631 - ROR1 antibody immunoconjugates (2025-10-14),

4. 12263164 - Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor (2025-04-01),

5. 12161626 - Uses of indolinone compounds (2024-12-10),

6. 11771696 - Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor (2023-10-03),

7. 11654143 - Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JAK-2 inhibitor, and/or a BCL-2 inhibitor (2023-05-23),

8. 11285132 - Uses of indolinone compounds (2022-03-29),

9. 11166951 - Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JAK-2 inhibitor, and/or a BCL-2 inhibitor (2021-11-09),

10. 11154554 - Therapeutic combinations of a MEK inhibitor and a BTK inhibitor (2021-10-26),

11. 11090302 - Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor (2021-08-17),

12. 10646470 - Uses of indolinone compounds (2020-05-12),

13. 10335496 - ROR1 antibody immunoconjugates (2019-07-02),

14. 10328080 - Therapeutic combination of PI3K inhibitor and a BTK inhibitor (2019-06-25),

15. 10272083 - Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor (2019-04-30),

Title: Brian Lannutti - Innovative Inventor from Solana Beach

Introduction: Brian Lannutti is a talented inventor based in Solana Beach, California, known for his groundbreaking contributions to various industries.

Latest Patents: Brian Lannutti holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of innovative ideas.

Career Highlights: With a career spanning over two decades, Brian has successfully brought numerous inventions to life, revolutionizing the way we interact with everyday products.

Collaborations: Throughout his career, Brian has collaborated with leading companies, research institutions, and universities to further develop his inventions and bring them to the market.

Conclusion: Brian Lannutti's passion for innovation and his relentless drive to create have solidified his position as a respected inventor in the industry.

Profile summary based on public USPTO records.